Dragos Plesca, PharmD, PhD, BCOP, will be honored with the very first ASBMT Pharmacy SIG New Investigator Award at the BMT Tandem Meetings, February in Salt Lake City.
Pharmacy resident program director at the Carolinas Medical Center and Levine Cancer Institute in Charlotte, NC, Dr. Plesca’s project title is “Acquired immunity in multiple myeloma patients undergoing maintenance therapy post autologous stem cell transplantation.” His research will be fully funded in the amount of $25,000 per year for two years, and is sponsored by Takeda Oncology.
“This award will offer the opportunity to gain invaluable knowledge in the humoral and acquired immunity of multiple myeloma patients undergoing maintenance therapy post-transplantation, and at the same time will promote involvement in clinical and translational research by new pharmacist investigators,” said Dr. Plesca.
As the PGY2 Oncology Pharmacy Residency Program Director and member of the PGY1 Pharmacy Residency Advisory Committee, he mentors trainees as well as new practitioners in various research studies aimed at improving the outcomes of patients with cancer. He has served as the chair of the ASBMT Pharmacy SIG Research Subcommittee in the past, and is planning to continue dedicating time and effort to promoting research initiatives in the field of cellular therapy and stem cell transplantation by both junior and senior pharmacy practitioners.
This is the first time the ASBMT Pharmacy SIG has given this New Investigator Award. The winners of the ASBMT New Investigator Awards, given annually for nearly 10 years, will be announced in the coming months.
Back to the December 2017 issue of eNews.